Profile
ABCM VRTX REGN SGEN ARGX ALNY
Company Name Abcam plc Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $5.52B $128.84B $64.28B $43.15B $39.39B $33.74B
Employees 1.76K 6.10K 15.16K 3.26K 1.60K 2.23K
CEO Mr. Alan Thomas Hirzel BS, M.B.A., M.S. Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Mr. Timothy Van Hauwermeiren EMBA, M.Sc. Dr. Yvonne L. Greenstreet M.B.A., M.D.
Ratings
ABCM VRTX REGN SGEN ARGX ALNY
Quant Rating Score 2 4 3 3 1
Quant Rating Sell Buy Neutral Neutral Strong Sell
Trading
ABCM VRTX REGN SGEN ARGX ALNY
Last Close $23.99 $429.6 $547.67 $228.74 $569.12 $258.35
High 52 $23.99 $516.74 $1201.76 $228.74 $671.75 $296.75
Low 52 $23.99 $396.64 $546.39 $228.74 $356.01 $146.93
Price vs. 52 Week High 0 % -16.86 % -54.43 % 0 % -15.28 % -12.94 %
Price vs. 52 Week Low 0 % 8.31 % 0.23 % 0 % 59.86 % 75.83 %
Total Return
ABCM VRTX REGN SGEN ARGX ALNY
1 Month Return 0 % -10.93 % -4.95 % 0 % 0.94 % 6.21 %
3 Month Return 0 % -8.46 % -22.81 % 0 % -11.99 % -6.46 %
6 Month Return 0 % -16.86 % -33.89 % 0 % -4.51 % -6.88 %
9 Month Return 0 % -8.29 % -51.59 % 0 % 6.38 % -4.14 %
YTD Return 0 % 6.68 % -23.12 % 0 % -7.46 % 9.79 %
1 Year Return 0 % 2.53 % -43.42 % 0 % 48.77 % 70.67 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABCM VRTX REGN SGEN ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.15 % - - -
Dividend Paid and Capex Coverage Ration (TTM) 1.05 % -1.65 % 3.85 % -2.27 % -44.32 % -1.49 %
Dividend Per Share (TTM) - - 0.88 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Growth
ABCM VRTX REGN SGEN ARGX ALNY
Asset Growth 7.15 % -0.87 % -1.21 %
Gross Profit Growth 20.44 % 10.25 % 22.93 %
Revenue Growth 14.68 % 11.66 % 24.65 %
Revenue 3 Year 26.28 % 45.6 % 91.56 %
Revenue 5 Year 38.49 % 163.93 % 215.48 %
Revenue 10 Year 155.91 % 1632.15 % 494.04 %
EBIT Growth -243.66 % -93.69 % 10.13 %
Net Income Growth -293.18 % -114.8 % 9.51 %
Net Income 3 Yeari Growth Per Share -161.73 % -122.89 % -763.59 %
Net Income 5 Yeari Growth Per Share -112.2 % -145.38 % -276.93 %
Net Income 10 Yeari Growth Per Share -122.5 % 33.84 % -624.16 %
Operating Income Growth -243.66 % -105.41 % 10.13 %
Operating Cash Flow Growth (CFG) -54.37 % -113.93 % 9.07 %
Operating 3 Year CFG -58.65 % -118.65 % -147.99 %
Operating 5 Year CFG -59.52 % -131.3 % -195.86 %
Operating 10 Year CFG -37.07 % 12.43 % -2622.09 %
EPS Growth -293.75 % -114.8 % 10.81 %
EPS Diluted Growth -293.75 % -114.97 % 10.81 %
Book Value Per Share 10.89 % -6.59 % -9.83 %
Share Holder 3 Year Equity Growth Per Share 31.28 % 62.6 % 33.72 %
Share Holder 5 Year Equity Growth Per Share 84.54 % 168.85 % 220.81 %
Share Holder 10 Year Equity Growth Per Share 269.11 % 1265.7 % 691.19 %
Dividend Per Share Growth 0.09 % - -
Dividend 3 Year Growth Per Share -9.23 % - -
Dividend 5 Year Growth Per Share 1 % - -
Dividend 10 Year Growth Per Share 72.85 % - -
Debt Growth -2.53 % 116.42 % -23.28 %
Free Cash Flow Growth -506.45 % -124.1 % 3.67 %
Updated On 31 Dec 2022 31 Dec 2024 31 Dec 2022
Profitability
ABCM VRTX REGN SGEN ARGX ALNY
Gross Profit Margin TTM 71.21 % 86.09 % 84.94 % 72.37 % 46.33 % 86.01 %
Return on Assets TTM 0.45 % -2.38 % 11.98 % -11.76 % 13.45 % -6.4 %
Return on Equity TTM 0.76 % -3.28 % 14.77 % -16.53 % 16.83 % -509.33 %
Return on Capital Employed TTM 0.8 % -1.3 % 11.35 % -16.87 % -0.31 % -3.68 %
Net Income Per EBT TTM 93.62 % -215.53 % 90.27 % 100.55 % 25990.14 % 75.89 %
EBT Per Ebit TTM 73.44 % -100.69 % 129.3 % 94.01 % -18.79 % 308.03 %
EBIT Per Revenue TTM 2.03 % -2.24 % 27.37 % -36.09 % -0.77 % -4.91 %
Cash Flow To Debt Ratio TTM 27.38 % -28.16 % 146.15 % -185.98 % -201.37 % -3.47 %
Receivables Turnover TTM - 6.84 2.53 1.98 2.46 5.62
Payables Turnover TTM 7.04 3.71 3.01 1.54 1.83 3.37
Inventory Turnover TTM 1.56 1.27 0.66 0.65 2.93 5.01
Fixed Asset Turnover TTM 195.05 % 425.82 % 300.07 % 256.83 % 5106.8 % 337.41 %
Asset Turnover TTM 31.98 % 48.84 % 37.52 % 34.46 % 35.83 % 55.72 %
Operating Cash Flow Per Share TTM 0.3 -1.91 37.05 -1.12 -1.07 -0.35
Free Cash Flow Per Share TTM 0.01 -3.07 28.3 -1.62 -1.09 -0.58
Cash Per Share TTM 45.81 % 2375.11 % 7825.12 % 657.5 % 4597.04 % 2024.29 %
Operating Cash Flow Sales Ratio TTM 19.94 % -4.48 % 28.06 % -16.85 % -3.54 % -1.92 %
Free Cash Flow Operating Cash Flow Ratio TTM 4.93 % 160.43 % 76.4 % 144.14 % 102.26 % 167.11 %
Cash Flow Coverage Ratios TTM 27.38 % -28.16 % 146.15 % -185.98 % -201.37 % -3.47 %
Price To Free Cash Flows Ratio TTM - -163.02 21.29 -141.85 -505.86 -447.57
Price To Operating Cash Flows Ratio TTM 40.46 -261.97 16.35 -203.89 -601.06 -745.64
Price Cash Flow Ratio TTM 40.46 -261.97 16.35 -203.89 -601.06 -745.64
Income Statement (TTM)
ABCM VRTX REGN SGEN ARGX ALNY
Revenue $0.36B $11.02B $14.2B $1.96B $2.19B $2.25B
Gross Profit $0.27B $9.49B $12.23B $1.55B $1.96B $1.92B
Gross Profit Ratio 74.79% 86.11% 86.13% 79.1% 89.62% 85.62%
EBITDA $0.04B $0.48B $5.32B $-0.62B $0B $-0.18B
Net Income $-0.01B $-0.54B $4.41B $-0.61B $0.83B $-0.28B
EPS Diluted -0.04 -2.08 38.34 -3.3 12.78 -2.16
Balance Sheet (MRQ)
ABCM VRTX REGN SGEN ARGX ALNY
Long Term Debt $0.1B $1.66B $1.98B $0.04B $0.03B $0B
Total Liabilities $0.33B $6.12B $8.41B $0.87B $0.7B $4.17B
Total Equity $0.73B $16.41B $29.35B $2.8B $5.5B $0.07B
Total Investments $0B $6.65B $15.42B $1.42B $1.93B $1.73B
Total Debt $0.22B $1.75B $2.7B $0.04B $0.04B $1.3B
Total Assets $1.06B $22.53B $37.76B $3.67B $6.2B $4.3B
Cash Flow Statement (TTM)
ABCM VRTX REGN SGEN ARGX ALNY
Net Income $-0.01B $-0.54B $4.41B $-0.61B $0.8B $-0.28B
Inventory $-0.01B $-0.52B $-0.62B $-0.23B $-0.09B $0.01B
Dividends Paid $-0.03B $0B $0B $0B $0B $0B
Operating Cash Flow $0.03B $-0.49B $4.42B $-0.45B $-0.08B $-0.01B
Capital Expenditure $-0.04B $-0.3B $-0.76B $-0.08B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 24.375
ABCL AbCellera Biologics Inc. 2.02
ABEO Abeona Therapeutics Inc. 5.265
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 0.9802
ABPWW 0.02
ABSI Absci Corporation 2.74
ABUS Arbutus Biopharma Corporation 3.22
ABVC ABVC BioPharma, Inc. 1.21
ABVX Abivax SA American Depositary Shares 6.7
ACAD ACADIA Pharmaceuticals Inc. 17.44
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.608
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.34
ACIU AC Immune SA 1.68
ACLX Arcellx, Inc. 57.52
ACRV Acrivon Therapeutics, Inc. Common Stock 1.175
ETFs With Exposure to ABCM
Ticker ETF Name Weight Percentage Price
IBB iShares Biotechnology ETF 0.40175 116.55
SPDW SPDR Portfolio Developed World ex-US ETF 0.033598 38.43
BIB ProShares Ultra Nasdaq Biotechnology 0.189373 39.68
MNA IQ Merger Arbitrage ETF 6.85 34.75
ONEQ Fidelity Nasdaq Composite Index ETF 0.01 70.57
FPXI First Trust International Equity Opportunities ETF 0.45 50.9
ISCF iShares MSCI Intl Small-Cap Multifactor ETF 0.18111 36.125
MRGR ProShares Merger ETF 3.16608 41.815
FPXE First Trust IPOX Europe Equity Opportunities ETF 0.27 28.13
VINEX Vanguard International Explorer Fund Investor Shares 0.22 17.86
VGHAX Vanguard Health Care Fund Admiral Shares 0.36 71.65
VGHCX Vanguard Health Care Fund Investor Shares 0.36 169.94
BMED BlackRock Future Health ETF 1.68229 23.6
IBBQ Invesco Nasdaq Biotechnology ETF 0.539 19.495
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.48139 5.111
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.53798 5.75
DFIC Dimensional International Core Equity 2 ETF 0.00052105 29.36
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.53798 5.743
CTRU ARK Transparency ETF 0.96 12.897
Unlock